Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Senators Blumenthal, Casey and Harkin Request GAO Investigation into Drug Shortages

Monday, May 09, 2011

Senators Richard Blumenthal (D-CT), Robert Casey (D-PA), and Tom Harkin (D-IA) have sent a letter to the Government Accountability Office (GAO) requesting an investigation into drug shortages.  Senator Harkin is chairman of the Committee on Health, Education, Labor, and Pensions - the committee with primary jurisdiction on this issue.  The letter comes on the heels of a letter previously sent solely by Senator Blumenthal requesting the investigation. Senator Blumenthal spoke on the issue of drug shortages before more than 500 anesthesiologists at the 2011 ASA Legislative Conference. 

In the letter, the Senators state, "We have met with a variety of stakeholders who report that hospitals around the country are experiencing frequest shortages of life-saving FDA-approved pharmaceutical products. These shortages directly threaten public health by preventing patients from accessing medications that are essential to their care."

ASA supports a GAO investigation that could help bring to light many of the multitude of causes of drug shortages as well as make recommendations on how to alleviate the record number of shortages.

Please visit ASA's Drug Shortages page for more information.

 

 

 

 

 

 

« Back to Washington Alerts